XXII: 22nd Century Group Market Cap to Revenue Ratio

Stable cash flow from contract manufacturing supports 22nd Century Group (XXII), creating a foundation for growth. Breeding patents and FDA plans to reduce nicotine further enhance this potential. The P/S time series on the GURU.Markets chart reflects valuation dynamics, where the 0.00 level captures recent values. Its status as a biotech leader in national health confirms the brand's uniqueness.

XXII: 22nd Century Group Inc. P/S Multiple 07/04/2022 - 11/13/2026

Metric breakdowns and analytics for 22nd Century Group (XXII)

- stock price and consensus target price:

Share Price xxiicentury.com|XXII - Analyst Consensus Forecast

- market capitalization information:

Market Capitalization 22nd Century|XXII - Real Price to Acquire Entire Company

- business book valuation details:

Accounting Value of a Share 22nd Century Group|XXII - Book Capitalization|Market Cap to Net Assets Ratio xxiicentury.com|XXII - Company Total Assets

- business debt structure and liquidity details:

- earnings and valuation multiples information:

XXII - Net Income|Expected Net Profit 22nd Century Group|XXII - Price to Earnings Ratio|Future Price to Earnings Multiple xxiicentury.com|XXII - PEG Multiple|Enterprise Value to EBITDA Multiple 22nd Century|XXII - Profit before payment of interest, taxes and amortization|Earnings per share for the trailing year 22nd Century Group|XXII - Earnings per share for the last twelve months|Earnings per share growth in annualized terms for the last twelve months xxiicentury.com|XXII - Net earnings per share growth this year|Earnings growth forecast for next year 22nd Century Group

- issuer revenue and sales details:

XXII - Company Revenue|Company Expected Revenue xxiicentury.com|XXII - Market Cap to Revenue|Market Cap to Projected Revenue 22nd Century

Summary company analytics:22nd Century Group Inc.

Mass-produced product of 22nd Century Group Inc.

Investors must determine whether the market value of 22nd Century Group (XXII) is overvalued against the backdrop of current operational risks. By analyzing the price-to-sales ratio, we compare market capitalization with sales volume, which is critical for a holding company undergoing a painful transition to contract manufacturing and asset divestment to stabilize its balance sheet.

Who 22nd Century Group competes with